2024. 04. 28
New C2H Report: Deucravacitinib (Sotyktu)
2024. 03. 13
New C2H Report: Molnupiravir (Lagevrio)
New C2H Report: Finerenone (Kerendia)
View all news
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events
View all reports